These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 12807116)

  • 21. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic equivalents in clinical practice.
    Benson MD
    Int J Fertil Womens Med; 2001; 46(2):89-94. PubMed ID: 11374660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic drugs revisited.
    Med Lett Drugs Ther; 2009 Oct; 51(1323):81-2. PubMed ID: 19838144
    [No Abstract]   [Full Text] [Related]  

  • 24. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
    Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J
    Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R; Gelenberg AJ
    Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Authorized generic drugs, price competition, and consumers' welfare.
    Berndt ER; Mortimer R; Bhattacharjya A; Parece A; Tuttle E
    Health Aff (Millwood); 2007; 26(3):790-9. PubMed ID: 17485758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic low-molecular-weight heparins: some practical considerations.
    Fareed J; Leong WL; Hoppensteadt DA; Jeske WP; Walenga J; Wahi R; Bick RL
    Semin Thromb Hemost; 2004 Dec; 30(6):703-13. PubMed ID: 15630677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biosimilars or follow-on biologics in dermatology].
    Puig L
    Actas Dermosifiliogr; 2010; 101(1):4-6. PubMed ID: 20109387
    [No Abstract]   [Full Text] [Related]  

  • 30. Issues in the use of generic antiarrhythmic drugs.
    Reiffel JA
    Curr Opin Cardiol; 2001 Jan; 16(1):23-9. PubMed ID: 11124715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What are narrow therapeutic index drugs?
    Levy G
    Clin Pharmacol Ther; 1998 May; 63(5):501-5. PubMed ID: 9630822
    [No Abstract]   [Full Text] [Related]  

  • 32. The impact of generic drugs on the cost of transplantation medical care.
    Olyaei AJ; deMattos AM; Bennett WM
    Transplant Proc; 1999 May; 31(3A Suppl):31S-34S. PubMed ID: 10330957
    [No Abstract]   [Full Text] [Related]  

  • 33. Are drugs within a class interchangeable?
    Furberg CD; Herrington DM; Psaty BM
    Lancet; 1999 Oct; 354(9185):1202-4. PubMed ID: 10513728
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding bioequivalence testing.
    Benet LZ
    Transplant Proc; 1999 May; 31(3A Suppl):7S-9S. PubMed ID: 10330950
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanistic modeling of generic orally inhaled drug products: A workshop summary report.
    Walenga RL; Butler C; Craven BA; Longest PW; Mohamed R; Newman B; Olsson B; Hochhaus G; Li BV; Luke MC; Zhao L; Przekwas A; Lionberger R
    CPT Pharmacometrics Syst Pharmacol; 2023 May; 12(5):560-574. PubMed ID: 36330693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic drugs.
    Gross D
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2003 May; (IB61):1-18. PubMed ID: 12807116
    [No Abstract]   [Full Text] [Related]  

  • 37. Generic drugs: an overview.
    Helgeland D
    S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
    [No Abstract]   [Full Text] [Related]  

  • 38. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
    Heller WM
    Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
    [No Abstract]   [Full Text] [Related]  

  • 39. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
    Hendeles L; Hochhaus G; Kazerounian S
    Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.